Search
for
Sort by
Research 241–270 of 1000+
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Female pattern hair loss
- Screening for 21-hydroxylase–deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study
- Particulate matter 2.5 damages skin cells by inducing oxidative stress, subcellular organelle dysfunction, and apoptosis
- The diagnosis of polycystic ovary syndrome in adolescents
- Dermatoses of pregnancy
- Guidelines for the management of alopecia areata
- Cutaneous complications of chemotherapeutic agents
- Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial
- Liposomal systems as drug delivery vehicles for dermal and transdermal applications
- An Update of Congenital Adrenal Hyperplasia
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- Recognition and management of <i>Staphylococcus aureus</i> toxin‐mediated disease
- Hormesis and medicine
- Adult polycystic ovary syndrome begins in childhood
- Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering
- Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- Tissue regenerative delays and synthetic lethality in adult mice after combined deletion of Atr and Trp53
- EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency
- Dermatoses of Pregnancy - Clues to Diagnosis, Fetal Risk and Therapy
- Dermatologic manifestations of endocrine disorders
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Large Scale Gene Expression Profiles of Regenerating Inner Ear Sensory Epithelia
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- Alopecia areata: An update
- Recent progress in PLGA-based microneedle-mediated transdermal drug and vaccine delivery
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Oxidative Damage Control in a Human (Mini-) Organ: Nrf2 Activation Protects against Oxidative Stress-Induced Hair Growth Inhibition